Centre for Translational Microbiome Research aims to solve key challenges in reproductive health and gastroenterology

The human body is host to trillions of bacteria, viruses and fungi. This vast community, called the microbiota, contains millions of genes which are collectively known as the microbiome.  Scientists have linked dysfunction of the microbiota and microbiome to a wide range of conditions, from inflammatory bowel disease (IBD) to preterm birth - the leading cause of death in children under five.

Ferring is collaborating with the Karolinska Institute and Science for Life Laboratory on the Centre for Translational Microbiome Research (CTMR), where researchers are exploring the role that the microbiome plays in human health and disease.

Watch the video below to find out why this collaboration has the potential to improve the way that doctors diagnose, prevent and treat diseases, and how the microbiome could help solve some of today’s key challenges in reproductive health, neonatology and gastroenterology.

  

“One of our major challenges is premature delivery, where the causes are often unknown. We hope that our research on the microbiome will give us insights on mothers who are at high risk so that we can identify them early, and treat them accordingly.”

Alkistis Skalkidou
Adj Professor of Obstetrics & Gynaecology, Uppsala University Hospital  

 

Headquarters

FERRING INTERNATIONAL CENTER S.A.
CH. DE LA VERGOGNAUSAZ 50
1162 SAINT-PREX
SWITZERLAND

TEL:  +41 58 301 00 00
FAX: +41 58 301 00 10

CONTACT

Global Locator